Locked Nucleic Acid Holds Promise in the Treatment of Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|11|1138-1142

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.11, 2008-04, pp. : 1138-1142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Future Promise of siRNA and Other Nucleic Acid Based Therapeutics for the Treatment of Chronic HCV

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 6, Iss. 1, 2006-03 ,pp. : 43-56

Bentham Science Publishers

Access to resources Recommend Favorite

Nucleic Acid for the Treatment of Cancer: Genetic Vaccines and DNA Adjuvants

By  

Current Pharmaceutical Design, Vol. 7, Iss. 16, 2001-11 ,pp. : 1641-1667

Bentham Science Publishers

Access to resources Recommend Favorite

Combinatorial Application of Nucleic Acid-Based Agents Targeting Protein Kinases for Cancer Treatment

By  

Current Pharmaceutical Design, Vol. 14, Iss. 11, 2008-04 ,pp. : 1098-1112

Bentham Science Publishers

Access to resources Recommend Favorite

Nucleic Acid-based Molecular Treatment of Allergy

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 3, Iss. 1, 2004-03 ,pp. : 63-73

Bentham Science Publishers

Access to resources Recommend Favorite

The promise and challenges of targeting RSK for the treatment of cancer

By Stratford Anna L   Dunn Sandra E  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 1, 2011-01 ,pp. : 1-4

Informa Healthcare

Access to resources Recommend Favorite